Free Trial

RODMAN&RENSHAW Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at RODMAN&RENSHAW. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by RODMAN&RENSHAW.

MarketBeat Brokerage Ranking:
Average 12-Month ROI of Buy Recommendations: Subscribe to Unlock


MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionRatingPrice TargetDetailsActions
BioXcel Therapeutics stock logo
BTAI
BioXcel Therapeutics
$1.73
-4.4%
3/19/2025E. PirosUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of BioXcel Therapeutics (NASDAQ:BTAI) on 3/19/2025
Telomir Pharmaceuticals stock logo
TELO
Telomir Pharmaceuticals
$2.29
+11.2%
2/20/2025E. PirosUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Telomir Pharmaceuticals (NASDAQ:TELO) on 2/20/2025
PolyPid stock logo
PYPD
PolyPid
$3.74
-0.5%
1/28/2025B. FolkesUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of PolyPid (NASDAQ:PYPD) on 1/28/2025
INmune Bio stock logo
INMB
INmune Bio
$2.78
-2.8%
1/28/2025E. PirosUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of INmune Bio (NASDAQ:INMB) on 1/28/2025
Cardiol Therapeutics stock logo
CRDL
Cardiol Therapeutics
$1.40
-2.8%
1/28/2025B. FolkesUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Cardiol Therapeutics (NASDAQ:CRDL) on 1/28/2025
Atara Biotherapeutics stock logo
ATRA
Atara Biotherapeutics
$12.23
-0.2%
1/21/2025T. ButlerDowngradeStrong-Buy -> HoldView details for RODMAN&RENSHAW rating of Atara Biotherapeutics (NASDAQ:ATRA) on 1/21/2025
Atara Biotherapeutics stock logo
ATRA
Atara Biotherapeutics
$12.23
-0.2%
12/20/2024T. ButlerUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Atara Biotherapeutics (NASDAQ:ATRA) on 12/20/2024
TuHURA Biosciences stock logo
HURA
TuHURA Biosciences
$2.84
-3.7%
12/19/2024T. ButlerUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of TuHURA Biosciences (NASDAQ:HURA) on 12/19/2024
Rockwell Medical stock logo
RMTI
Rockwell Medical
$1.12
11/14/2024B. FolkesUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Rockwell Medical (NASDAQ:RMTI) on 11/14/2024
Omeros stock logo
OMER
Omeros
$3.59
-6.0%
11/14/2024B. FolkesUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Omeros (NASDAQ:OMER) on 11/14/2024
Eupraxia Pharmaceuticals stock logo
EPRX
Eupraxia Pharmaceuticals
$5.54
+9.5%
11/14/2024B. FolkesUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 11/14/2024
Achieve Life Sciences stock logo
ACHV
Achieve Life Sciences
$2.70
-1.1%
11/14/2024B. FolkesUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Achieve Life Sciences (NASDAQ:ACHV) on 11/14/2024
Bicara Therapeutics stock logo
BCAX
Bicara Therapeutics
$11.93
+1.2%
11/5/2024T. ButlerUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Bicara Therapeutics (NASDAQ:BCAX) on 11/5/2024
Quince Therapeutics stock logo
QNCX
Quince Therapeutics
$1.86
10/29/2024E. PirosUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Quince Therapeutics (NASDAQ:QNCX) on 10/29/2024
Alto Neuroscience stock logo
ANRO
Alto Neuroscience
$3.05
-0.7%
10/23/2024E. PirosDowngradeStrong-Buy -> HoldView details for RODMAN&RENSHAW rating of Alto Neuroscience (NYSE:ANRO) on 10/23/2024
Nkarta stock logo
NKTX
Nkarta
$2.14
-4.0%
10/9/2024T. ButlerUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Nkarta (NASDAQ:NKTX) on 10/9/2024
Kyverna Therapeutics stock logo
KYTX
Kyverna Therapeutics
$4.24
-2.1%
10/9/2024T. ButlerUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Kyverna Therapeutics (NASDAQ:KYTX) on 10/9/2024
MIRA Pharmaceuticals stock logo
MIRA
MIRA Pharmaceuticals
$1.74
-3.3%
9/30/2024E. PirosUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of MIRA Pharmaceuticals (NASDAQ:MIRA) on 9/30/2024
Biomea Fusion stock logo
BMEA
Biomea Fusion
$1.81
-2.2%
9/26/2024T. ButlerUpgradeStrong-BuyView details for RODMAN&RENSHAW rating of Biomea Fusion (NASDAQ:BMEA) on 9/26/2024

MarketBeat Community Rating for RODMAN&RENSHAW

Community Ranking:  2.5 out of 5 (
2.5 of 5 stars)
Outperform Votes:  21,343 (Vote Outperform)
Underperform Votes:  21,879 (Vote Underperform)
Total Votes:  43,222
MarketBeat's community ratings are surveys of what our community members think about RODMAN&RENSHAW and other research firms. Vote "Outperform" if you believe RODMAN&RENSHAW's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RODMAN&RENSHAW's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.